Skip to main content
Top of the Page

Membership renewals are open. Contact [email protected] for account assistance.

Cancer-Associated Thrombosis

Speaker headshot
Cancer‑associated thrombosis (CAT) is a serious complication that affects outcomes for patients all too often.   Stephanie Carlin will provide a comprehensive overview of CAT, giving pharmacy teams evidence‑based insights to make more confident, informed decisions for this high‑risk population.

 

 

 

Learning Objectives:
By the end of this session, participants will be able to:

  • Discuss the epidemiology of cancer-associated thrombosis (CAT)
  • Describe patient, disease and medication-related risk factors for CAT
  • Differentiate treatment options for CAT: Direct Oral Anticoagulants (DOACs) vs Low Molecular Weight Heparin (LMWH)
  • Discuss use of anticoagulation in special populations in CAT (e.g. renal impairment, drug interactions)
When
3/3/2026 1:00 PM - 2:00 PM
Eastern Standard Time
Where
Webinar Ottawa CANADA

Sign In

Back to Top